Get started
Work

CNS Disease at Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Year: 2013
Type: article
Abstract: Relapse is the primary cause of treatment failure post alloHCT. We sought to identify risk factors that predict relapse of hematologic malignancies after allogeneic hematopoietic cell transplantation (alloHCT) to identify those at highest risk of relapse who may benefit from novel therapies.
DOI: 10.1016/j.bbmt.2012.11.340
Authors: Nirali Shah, Michael J. Borowitz, Seth Steinberg, Nancy Robey, Christopher Gamper, Heather Symons, David Loeb, Alan S. Wayne, Allen Chen
Institutions: National Institutes of Health, Johns Hopkins University, National Cancer Institute, Johns Hopkins Hospital, National Cancer Institute, Center for Cancer Research
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2033926482
FWCI:
Cites:
Cited by:
Related to: 10